Viracta Therapeutics Company

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.

Last Funding Type: Post-IPO Equity
Funding Status: IPO
Headquarters: Cardiff By The Sea, California, United States
Founded Date: 2007
Investor Type: IPO
Last Funding Date: 2021
Total Funding: 184899999
Technology: Cancer
Employee Number: 11-50
Estimated Revenue: $10M to $50M
Investors Number: 19
Industry: Biopharma, Biotechnology, Medical, Pharmaceutical, Therapeutics